2025
Chapter 14 Impact of androgens on cardiovascular risk in women with polycystic ovary syndrome and transgender men
Stachenfeld N, Alexander L, Bender J, Weinzimer S, Pal L, Reckelhoff J. Chapter 14 Impact of androgens on cardiovascular risk in women with polycystic ovary syndrome and transgender men. 2025, 279-293. DOI: 10.1016/b978-0-443-22266-5.00014-8.Peer-Reviewed Original ResearchGender-affirming hormone therapyAE-PCOSTransgender menPolycystic ovary syndromeFemale endocrinopathyHigher androgenLong-term consequencesMild hypertensionEndothelial dysfunctionAssociated with endothelial dysfunctionIncreased risk of endothelial dysfunctionRisk of endothelial dysfunctionMenImpact of androgensHyperandrogenemiaHormone therapyHigher androgen levelsInfertilityAndrogen levelsCardiovascular riskVascular systemIncreased riskMetabolic dysfunctionVascular functionCardiovascular disease
2015
Menopause and the Heart
Nkonde-Price C, Bender JR. Menopause and the Heart. Endocrinology And Metabolism Clinics Of North America 2015, 44: 559-564. PMID: 26316243, DOI: 10.1016/j.ecl.2015.05.005.Peer-Reviewed Original ResearchConceptsPostmenopausal hormone replacement therapyPostmenopausal US womenHormone replacement therapyHormone therapy initiationHealth topicsCause of deathWomen's health topicsTherapy initiationCardiovascular riskOngoing trialsReplacement therapyCardiovascular concernsClinical trialsCardiovascular diseaseUS womenCurrent recommendationsDiscordant resultsTrialsMenopauseTherapyDiseaseWomen